Toronto Dominion Bank
SRPT icon

Toronto Dominion Bank’s Sarepta Therapeutics SRPT Stock Holding History

Toronto Dominion Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17
Closed -$330 – 2268
2025
Q3 		$330 Buy
17
+11
+183% +$196 ﹤0.01% 1859
2025
Q2 		$101 Buy
+6
New +$256 ﹤0.01% 1759
2022
Q1 		– Sell
-148,300
Closed -$13.4M – 1941
2021
Q4 		$13.4M Buy
+148,300
New +$12.7M 0.02% 426
2021
Q2 		– Sell
-10,129
Closed -$755K – 1487
2021
Q1 		$755K Sell
10,129
-3,913
-28% -$361K ﹤0.01% 933
2020
Q4 		$2.39M Buy
14,042
+1,643
+13% +$243K ﹤0.01% 761
2020
Q3 		$1.74M Buy
12,399
+1,151
+10% +$175K ﹤0.01% 754
2020
Q2 		$1.8M Buy
11,248
+1,191
+12% +$162K ﹤0.01% 743
2020
Q1 		$984K Sell
10,057
-2,960
-23% -$338K ﹤0.01% 763
2019
Q4 		$1.68M Buy
13,017
+1,008
+8% +$102K ﹤0.01% 790
2019
Q3 		$904K Buy
+12,009
New +$1.42M ﹤0.01% 964

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Toronto Dominion Bank's SRPT Position: Q4 2025 in Review

Toronto Dominion Bank sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 17 shares — an estimated $330 sold.

Toronto Dominion Bank first reported a position in SRPT in Q3 2019 and held it in 10 quarters. The position peaked at $13.4M in Q4 2021. 347 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Toronto Dominion Bank reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 17 Sarepta Therapeutics shares in Q4 2025, an estimated $330.
  • Toronto Dominion Bank first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 10 quarters.
  • Toronto Dominion Bank's Sarepta Therapeutics position peaked at $13.4M in Q4 2021.
  • 347 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.